首页> 外国专利> METHOD OF ACETYLSALICYLIC ACID BASED CORRECTION OF ENDOTHELIAL DYSFUNCTION IN L-NAME INDUCED NITRIC OXIDE DEFICIENCY

METHOD OF ACETYLSALICYLIC ACID BASED CORRECTION OF ENDOTHELIAL DYSFUNCTION IN L-NAME INDUCED NITRIC OXIDE DEFICIENCY

机译:基于乙酰水杨酸的L型诱导型一氧化氮缺乏症血管内皮功能障碍的纠正方法

摘要

FIELD: medicine.;SUBSTANCE: invention concerns medicine, particularly experimental cardiopharmacology and can be used for correction of endothelial dysfunction that is ensured by simulation thereof in experiment by daily intraperitoneal introduction to Wistar male rats within 7 days of N-nitro-L-arginine methyl ester in a dose 25 mg/kg. Degree of dysfunction development is estimated by relation of endothelium-independent to endothelium-dependent vasodilation. Correction of dysfunction is carried out by intragastric introduction of acetylsalicylic acid in a dose 8.6 mg/kg once a day.;EFFECT: method allows estimating correction of endothelial dysfunction in dynamics in specific simulation environment.;2 tbl
机译:发明领域本发明涉及医学,尤其是实验性心脏药理学,并且可以用于通过在N-硝基-L-精氨酸的7天内每天腹膜内引入Wistar雄性大鼠的实验中模拟的内皮功能障碍来校正内皮功能障碍。甲酯,剂量为25 mg / kg。通过内皮独立性与内皮依赖性血管舒张的关系来估计功能障碍的发展程度。通过每天一次在胃内引入乙酰水杨酸的剂量为8.6 mg / kg来进行功能障碍的校正。效果:该方法可在特定的模拟环境中估算动力学中的内皮功能障碍的校正。2tbl

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号